Compared to Estimates, Catalyst (CPRX) Q1 Earnings: A Look at Key Metrics

Catalyst Pharmaceutical (CPRX) reported $141.42 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 43.6%. EPS of $0.68 for the same period compares to $0.38 a year ago.The reported revenue represents a surprise of +8.92% over the Zacks Consensus Estimate of $129.84 million. With the consensus EPS estimate being $0.53, the EPS surprise was +28.30%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...